Dong-A Socio Holdings Co., Ltd.

KOSE:A000640 Stock Report

Market Cap: ₩709.5b

Dong-A Socio Holdings Past Earnings Performance

Past criteria checks 5/6

Dong-A Socio Holdings has been growing earnings at an average annual rate of 22.5%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 10.6% per year. Dong-A Socio Holdings's return on equity is 4.8%, and it has net margins of 4.2%.

Key information

22.5%

Earnings growth rate

22.1%

EPS growth rate

Pharmaceuticals Industry Growth11.3%
Revenue growth rate10.6%
Return on equity4.8%
Net Margin4.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Business Is Trailing The Market But Its Shares Aren't

Aug 13
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Business Is Trailing The Market But Its Shares Aren't

Key Things To Watch Out For If You Are After Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) 0.8% Dividend

Apr 29
Key Things To Watch Out For If You Are After Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) 0.8% Dividend

These 4 Measures Indicate That Dong-A Socio Holdings (KRX:000640) Is Using Debt Extensively

Apr 08
These 4 Measures Indicate That Dong-A Socio Holdings (KRX:000640) Is Using Debt Extensively

Are Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Mixed Financials Driving The Negative Sentiment?

Mar 18
Are Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Mixed Financials Driving The Negative Sentiment?

What Type Of Shareholders Own The Most Number of Dong-A Socio Holdings Co., Ltd. (KRX:000640) Shares?

Feb 25
What Type Of Shareholders Own The Most Number of Dong-A Socio Holdings Co., Ltd. (KRX:000640) Shares?

A Look At Dong-A Socio Holdings' (KRX:000640) Share Price Returns

Feb 04
A Look At Dong-A Socio Holdings' (KRX:000640) Share Price Returns

Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Jan 14
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Is It Smart To Buy Dong-A Socio Holdings Co., Ltd. (KRX:000640) Before It Goes Ex-Dividend?

Dec 24
Is It Smart To Buy Dong-A Socio Holdings Co., Ltd. (KRX:000640) Before It Goes Ex-Dividend?

Dong-A Socio Holdings (KRX:000640) Takes On Some Risk With Its Use Of Debt

Dec 13
Dong-A Socio Holdings (KRX:000640) Takes On Some Risk With Its Use Of Debt

Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Nov 22
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Revenue & Expenses Breakdown

How Dong-A Socio Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSE:A000640 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,220,98351,025294,4988,560
31 Mar 241,181,38155,552286,4738,069
31 Dec 231,132,00357,990274,5747,391
30 Sep 231,090,77635,900258,0607,208
30 Jun 231,070,98837,830241,8416,780
31 Mar 231,047,14325,287232,6566,428
31 Dec 221,014,86111,153232,7996,423
30 Sep 22987,86111,836221,6006,154
30 Jun 22956,81348,972217,9766,454
31 Mar 22912,99555,623203,5236,527
31 Dec 21881,94460,271196,1996,518
30 Sep 21842,393214,113192,7838,139
30 Jun 21811,312164,235190,05011,992
31 Mar 21794,394154,770184,25415,336
31 Dec 20783,316162,345176,94718,847
30 Sep 20773,05224,709176,16620,303
30 Jun 20791,14529,376171,57221,667
31 Mar 20784,28328,740177,05721,681
31 Dec 19769,68619,764174,46621,462
30 Sep 19761,452-164,895169,01722,683
30 Jun 19718,971-179,438163,86321,552
31 Mar 19713,877-162,620152,43220,812
31 Dec 18707,496-163,977153,57422,178
30 Sep 18693,71319,654155,47821,652
30 Jun 18704,63531,054160,66820,430
31 Mar 18699,01131,706162,69619,834
31 Dec 17690,26532,543165,65317,590
30 Sep 17682,17250,055176,90019,289
30 Jun 17657,70648,323173,80119,564
31 Mar 17710,128139,838175,94924,569
31 Dec 16726,166149,051169,82628,672
30 Sep 16754,540133,406171,70832,137
30 Jun 16785,651119,810166,61036,109
31 Mar 16730,41156,947159,14436,272
31 Dec 15704,73547,883155,99737,217
30 Sep 15700,83747,127129,54240,171
30 Jun 15656,03749,820132,26436,265
31 Mar 15630,0031,212131,03936,327
31 Dec 14630,6251,716128,35534,912
30 Sep 14617,9661,945124,92131,242
30 Jun 14604,68711,975113,73433,456
31 Mar 14604,02915,124111,76232,626
31 Dec 13570,8705,201109,07735,351

Quality Earnings: A000640 has high quality earnings.

Growing Profit Margin: A000640's current net profit margins (4.2%) are higher than last year (3.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A000640 has become profitable over the past 5 years, growing earnings by 22.5% per year.

Accelerating Growth: A000640's earnings growth over the past year (34.9%) exceeds its 5-year average (22.5% per year).

Earnings vs Industry: A000640 earnings growth over the past year (34.9%) exceeded the Pharmaceuticals industry 21.9%.

Return on Equity

High ROE: A000640's Return on Equity (4.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y